Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Intercure Ltd
(NQ:
INCR
)
1.340
UNCHANGED
Streaming Delayed Price
Updated: 3:58 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.340
Bid (Size)
1.220 (5)
Ask (Size)
1.600 (1)
Prev. Close
1.340
Today's Range
1.340 - 1.340
52wk Range
1.100 - 3.720
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company
September 14, 2024
InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A.
Via
Benzinga
Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany
August 30, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Performance
YTD
+2.77%
+2.77%
1 Month
-23.86%
-23.86%
3 Month
-34.31%
-34.31%
6 Month
-57.12%
-57.12%
1 Year
+19.64%
+19.64%
More News
Read More
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany
August 28, 2024
From
InterCure
Via
Business Wire
European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon
July 18, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
5 Value Stocks In The Healthcare Sector
May 08, 2023
Via
Benzinga
Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ
May 24, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
May 22, 2024
From
InterCure Ltd.
Via
Business Wire
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion
May 02, 2024
Via
Benzinga
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
May 01, 2024
From
InterCure Ltd.
Via
Business Wire
This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict
April 01, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
April 01, 2024
From
InterCure Ltd.
Via
Business Wire
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
March 22, 2024
From
InterCure Ltd.
Via
Business Wire
Canndoc Reports Record Revenue Amid Cannabis Market Turmoil
September 01, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 24, 2023
August 24, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For August 18, 2023
August 18, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Stocks That Hit 52-Week Lows On Wednesday
July 05, 2023
Via
Benzinga
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Medical Cannabis Company Better Is Suing InterCure For $35M
June 15, 2023
Via
Benzinga
InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details
May 16, 2023
Via
Benzinga
Marijuana Stock Movers For August 9, 2023
August 09, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Why Are Cannabis Stocks Trading Higher Today?
April 27, 2023
Via
Benzinga
Marijuana Stock Movers For August 8, 2023
August 08, 2023
Via
Benzinga
Cannabis Stock Movers For July 24, 2023
July 24, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.